or
forgot password

    • cancer clinical trials in manchester, NH

    • Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Diarrhea, Radiation Enteritis
    S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Lung Cancer
    S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
    Elliot Regional Cancer Center at Elliot Hospital
    Manchester, New Hampshire 03103
    Prostate Cancer
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Anemia, Head and Neck Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Head and Neck Cancer
    External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Prostate Cancer
    Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Colorectal Cancer
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Brain and Central Nervous System Tumors
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
    Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Breast Cancer, Osteoporosis
    Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Sarcoma
    Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Sarcoma
    Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Carcinoma of Unknown Primary
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Elliot Regional Cancer Center
    Manchester, New Hampshire 03103
    Anemia, Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Neutropenia
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    Elliot Regional Cancer Center at Elliot Hospital
    Manchester, New Hampshire 03103
    Breast Cancer
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Elliot Hospital
    Manchester, New Hampshire 03103
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer
    Elliot Hospital
    Manchester, New Hampshire 03103
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Stage I Endometrial Carcinoma, Stage II Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma